I

Inspirna, Inc. (formerly known as Rgenix, Inc.)

23 employees

Inspirna is a biotechnology company developing drugs for the treatment of cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
oncology
First in class therapies
Cancer
Drug Discovery
Health Care
microRNA
RGX-104

Date founded

2010

Funding rounds raised

Total raised

$55M

from 14 investors over 14 rounds

I

Inspirna, Inc. (formerly known as Rgenix, Inc.) raised $55M on July 11, 2022

Investors: Sofinnova Partners, Sixty Degree Capital, Lepu Medical Technology (Beijing) Co., Ltd., Novo Holdings, Sands Capital Management and Vivo Capital

I

Inspirna, Inc. (formerly known as Rgenix, Inc.) raised $40M on October 9, 2018

Investors: Novo Holdings, WuXi AppTec, Oceanpine Capital, Sofinnova Partners, Lepu Medical Technology (Beijing) Co., Ltd. and Partnership for New York City

I

Inspirna, Inc. (formerly known as Rgenix, Inc.) raised $33M on June 15, 2016

Investors: Sofinnova Partners and Novo Holdings

FAQ